ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract B27: A phase I dose escalation study of the MDM2 inhibitor DS-3032b in patients with advanced solid tumors and lymphomas
Mapping Intimacies
◽
10.1158/1535-7163.targ-15-b27
◽
2015
◽
Cited By ~ 1
Author(s):
Todd Bauer
◽
David Hong
◽
Neeta Somaiah
◽
Charles Cai
◽
Saeheum Song
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
◽
Mdm2 Inhibitor
Download Full-text
Related Documents
Cited By
References
A Phase I Dose–Escalation Study of Regorafenib (BAY 73–4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-11-1900
◽
2012
◽
Vol 18
(9)
◽
pp. 2658-2667
◽
Cited By ~ 208
Author(s):
Klaus Mross
◽
Annette Frost
◽
Simone Steinbild
◽
Susanne Hedbom
◽
Martin Büchert
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-009-1209-0
◽
2009
◽
Vol 66
(4)
◽
pp. 669-680
◽
Cited By ~ 32
Author(s):
Francisco Robert
◽
Alan Sandler
◽
Joan H. Schiller
◽
Glenn Liu
◽
Karen Harper
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-014-2567-9
◽
2014
◽
Vol 74
(5)
◽
pp. 917-925
◽
Cited By ~ 9
Author(s):
Carlos R. Becerra
◽
Paul Conkling
◽
Nicholas Vogelzang
◽
Hilary Wu
◽
Shengyan Hong
◽
...
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
Phase I Dose-Escalation Study of MEDI-573, a Bispecific, Antiligand Monoclonal Antibody against IGFI and IGFII, in Patients with Advanced Solid Tumors
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-14-0114
◽
2014
◽
Vol 20
(18)
◽
pp. 4747-4757
◽
Cited By ~ 30
Author(s):
Paul Haluska
◽
Michael Menefee
◽
Elizabeth R. Plimack
◽
Jonathan Rosenberg
◽
Donald Northfelt
◽
...
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
Abstract LB-410: Phase I dose escalation study of MM-121, a fully human monoclonal antibody to ErbB3, in patients with advanced solid tumors
10.1158/1538-7445.am2011-lb-410
◽
2011
◽
Cited By ~ 3
Author(s):
Crystal S. Denlinger
◽
Vicki L. Keedy
◽
James M. Cleary
◽
William Kubasek
◽
Matthew Onsum
◽
...
Keyword(s):
Monoclonal Antibody
◽
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Human Monoclonal Antibody
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
Abstract 1752: A phase I/IIa, first time in human, open-label dose-escalation study of GSK2636771 in subjects with advanced solid tumors with PTEN deficiency
10.1158/1538-7445.am2012-1752
◽
2012
◽
Cited By ~ 4
Author(s):
Samuel C. Blackman
◽
Shelby D. Gainer
◽
Benjamin B. Suttle
◽
Konstantine W. Skordos
◽
Joel D. Greshock
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Open Label
◽
Dose Escalation Study
◽
Label Dose
◽
First Time
Download Full-text
Abstract CT121: Phase I dose-escalation study of TAS-120, a highly selective, covalently bound FGFR inhibitor, in patients with advanced solid tumors
10.1158/1538-7445.am2018-ct121
◽
2018
◽
Cited By ~ 2
Author(s):
Rastislav Bahleda
◽
Funda Meric-Bernstam
◽
Lipika Goyal
◽
Ben Tran
◽
Helen He
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
◽
Covalently Bound
Download Full-text
Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors
The Oncologist
◽
10.1634/theoncologist.2018-0740
◽
2018
◽
Vol 24
(4)
◽
pp. 455
◽
Cited By ~ 4
Author(s):
Johanna C. Bendell
◽
Manish R. Patel
◽
Kathleen N. Moore
◽
Cynthia C. Chua
◽
Hendrik‐Tobias Arkenau
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
◽
Human Dose
Download Full-text
Phase I dose escalation study of topotecan combined with alternating schedules of paclitaxel and carboplatin in advanced solid tumors
Annals of Oncology
◽
10.1023/a:1011149623775
◽
2001
◽
Vol 12
(4)
◽
pp. 549-555
◽
Cited By ~ 5
Author(s):
F.R. Dunphy
◽
T.L. Dunleavy
◽
B.R. Harrison
◽
C.L. Cantrell
◽
J.L. Visconti
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors
Investigational New Drugs
◽
10.1007/s10637-016-0391-2
◽
2016
◽
Vol 35
(1)
◽
pp. 47-58
◽
Cited By ~ 10
Author(s):
Alex A. Adjei
◽
Patricia LoRusso
◽
Antoni Ribas
◽
Jeffrey A. Sosman
◽
Anna Pavlick
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Dose Escalation
◽
Mek Inhibitor
◽
Advanced Solid Tumors
◽
Dose Escalation Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close